Immediate Impact
36 standout
Citing Papers
Guidelines for accurate application of green and white analytical concepts: Merits Versus demerits with insights of significant milestones of assessment tools applied for antiviral drugs
2024 Standout
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019
2024 Standout
Works of Christine E. MacBrayne being referenced
Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1–Infected Individuals: SWIFT-C
2017
Development and validation of a dried blood spot assay for the quantification of ribavirin using liquid chromatography coupled to mass spectrometry
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Christine E. MacBrayne | 121 | 41 | 96 | 77 | 34 | 328 | |
| Derek N. Bremmer | 88 | 51 | 125 | 95 | 34 | 339 | |
| Jane Minton | 113 | 31 | 99 | 102 | 20 | 325 | |
| İlhan Özgüneş | 94 | 24 | 134 | 28 | 19 | 303 | |
| Yi Xin Liew | 39 | 23 | 117 | 54 | 21 | 329 | |
| Mary L. Townsend | 190 | 14 | 157 | 70 | 28 | 362 | |
| Anders Lannergård | 57 | 42 | 212 | 30 | 18 | 349 | |
| Lynora Saxinger | 114 | 27 | 108 | 24 | 33 | 352 | |
| Andrew A. Mahony | 148 | 39 | 146 | 27 | 19 | 330 | |
| Emmanuel Wey | 78 | 10 | 152 | 26 | 24 | 341 | |
| Kenta Ito | 61 | 25 | 124 | 53 | 31 | 311 |
All Works
Login with ORCID to disown or claim papers
Loading papers...